119 related articles for article (PubMed ID: 8378245)
1. The effect of gastric pH on the absorption of controlled-release theophylline dosage forms in humans.
Meyer MC; Straughn AB; Jarvi EJ; Wood GC; Vashi VI; Hepp P; Hunt J
Pharm Res; 1993 Jul; 10(7):1037-45. PubMed ID: 8378245
[TBL] [Abstract][Full Text] [Related]
2. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
Vashi VI; Meyer MC
J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
[TBL] [Abstract][Full Text] [Related]
3. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA
Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616
[TBL] [Abstract][Full Text] [Related]
4. pH-related changes in the absorption of dipyridamole in the elderly.
Russell TL; Berardi RR; Barnett JL; O'Sullivan TL; Wagner JG; Dressman JB
Pharm Res; 1994 Jan; 11(1):136-43. PubMed ID: 7908130
[TBL] [Abstract][Full Text] [Related]
5. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters.
Chung BH; Shim CK
J Pharm Sci; 1987 Oct; 76(10):784-7. PubMed ID: 3430341
[TBL] [Abstract][Full Text] [Related]
6. Influence of gastric pH changes on pharmacokinetic of a sustained-release formulation of theophylline.
Ferrari M; Olivieri M; Romito D; Biasin C; Barozzi E; Bassetti S
Riv Eur Sci Med Farmacol; 1991; 13(5-6):269-74. PubMed ID: 1819857
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and pharmacokinetics of theophylline in plain uncoated and sustained-release dosage forms in relation to smoking habit. I. Single dose study.
Horai Y; Ishizaki T; Sasaki T; Chiba K; Suganuma T; Echizen H; Ohnishi A
Eur J Clin Pharmacol; 1983; 24(1):79-87. PubMed ID: 6832206
[TBL] [Abstract][Full Text] [Related]
9. [Absorption profile and absolute bioavailability of a theophylline sustained-release preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1998 May; 48(5A):574-9. PubMed ID: 9676347
[TBL] [Abstract][Full Text] [Related]
10. Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs.
Yamada I; Goda T; Kawata M; Shiotuki T; Ogawa K
Chem Pharm Bull (Tokyo); 1990 Nov; 38(11):3112-5. PubMed ID: 2085896
[TBL] [Abstract][Full Text] [Related]
11. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
12. In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms.
el-Yazigi A; Sawchuk RJ
J Pharm Sci; 1985 Feb; 74(2):161-4. PubMed ID: 3989685
[TBL] [Abstract][Full Text] [Related]
13. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects.
Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):303-9. PubMed ID: 1743804
[TBL] [Abstract][Full Text] [Related]
14. The use of an in vitro dissolution and absorption system to evaluate oral absorption of two weak bases in pH-independent controlled-release formulations.
Sugawara M; Kadomura S; He X; Takekuma Y; Kohri N; Miyazaki K
Eur J Pharm Sci; 2005 Sep; 26(1):1-8. PubMed ID: 15961297
[TBL] [Abstract][Full Text] [Related]
15. The influence of enteral feedings on sustained-release theophylline absorption.
Plezia PM; Thornley SM; Kramer TH; Armstrong EP
Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
[TBL] [Abstract][Full Text] [Related]
16. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
Karim A; Burns T; Wearley L; Streicher J; Palmer M
Clin Pharmacol Ther; 1985 Jul; 38(1):77-83. PubMed ID: 4006379
[TBL] [Abstract][Full Text] [Related]
17. An in vivo single- and multiple-dose study of several marketed brands of conventional and controlled-release theophylline.
Kotzan JA; Vallner JV; Stewart JT; Honigberg IL; Brown WJ
Drug Intell Clin Pharm; 1984 Feb; 18(2):147-53. PubMed ID: 6697877
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the bioavailability and pharmacokinetic profile of a theophylline pellet formulation designed for once-daily dosage with a pellet preparation designed for twice-daily dosage].
Keinke O
Arzneimittelforschung; 1989 Nov; 39(11):1460-4. PubMed ID: 2619780
[TBL] [Abstract][Full Text] [Related]
19. [Absorption profile and absolute bioavailability of a theophylline--retard preparation].
Pabst G; Weber W; Barkworth MF; Müller M; Rehm KD
Arzneimittelforschung; 1990 Nov; 40(11):1218-24. PubMed ID: 2085333
[TBL] [Abstract][Full Text] [Related]
20. Dissolution studies of some sustained-release theophylline dosage forms.
Simons KJ; Simons FE; Plett KD; Scerbo C
J Pharm Sci; 1984 Jul; 73(7):939-42. PubMed ID: 6470957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
